This compound is a deuterium-labeled derivative of a sulfonamide, characterized by a phenyl-substituted oxazole ring and a benzenesulfonamide group. It is primarily used as an active pharmaceutical ingredient in research and pharmaceutical manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Trimetazidine-d8 Dihydrochloride
pharmaceutical raw material
Alpha3-(((1,1-Dimethylethyl)amino)methyl)-6-hydroxy-1,3-benzenedimethan-alpha1,alpha1,alpha3-d3-ol
pharmaceutical raw material
Metoprolol-D7 Hydrochloride
pharmaceutical raw material
(+/-)-Ondansetron-d5 (methylimidazole-d5)
pharmaceutical raw material
Valdecoxib
pharmaceutical raw material
4-(5-Methyl-3-phenyl-4-isoxazolyl)benzenesulfonyl chloride
pharmaceutical intermediate
5-Methyl-3,4-diphenylisoxazole
pharmaceutical intermediate
Parecoxib
pharmaceutical raw material
4-[3-phenyl-5-(trideuteriomethyl)-1,2-oxazol-4-yl]benzenesulfonamide
LNPDTQAFDNKSHK-FIBGUPNXSA-N
[2H]C([2H])([2H])C1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.